Mongolia Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Efficacy and Safety of Bifidobacterium Quadruple Live Tablets in Patients With T2DM and Constipation
Condition:   Type 2 Diabetes Mellitus With Complication Interventions:   Drug: Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live;   Drug: Siliankang simulating tablets Sponsors:   Peking Union Medical College Hospital;   First Affiliated Hospital of Harbin Medical University;   The Affiliated Hospital of Inner Mongolia Medical University;   Affiliated Hospital of Chengde Medical University;   The First Affiliated Hospital of Zhengzhou University;   Chinese  Academy of Sciences;   Hangzhou Grand Biologic Pharmaceutical, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2021 Category: Research Source Type: clinical trials